loading page

Familial Hypercholesterolemia presenting with Acute Coronary Syndrome (NSTEMI)
  • +3
  • Gaurav Chaudhary,
  • Akshyaya Pradhan,
  • SHUBHAJEET ROY,
  • Ayush Shukla,
  • Sharad Chandra,
  • Md. Al Hasibuzzaman
Gaurav Chaudhary
King George's Medical University Department of Cardiology
Author Profile
Akshyaya Pradhan
King George's Medical University Faculty of Medical Sciences
Author Profile
SHUBHAJEET ROY
King George's Medical University Department of Cardiology
Author Profile
Ayush Shukla
King George's Medical University Faculty of Medical Sciences
Author Profile
Sharad Chandra
King George's Medical University Department of Cardiology
Author Profile
Md. Al Hasibuzzaman
University of Dhaka

Corresponding Author:al.hasibuzzaman.hasib@gmail.com

Author Profile

Abstract

Familial hypercholesterolemia (FH) is the most common metabolic disorder and is inherited in an autosomal dominant fashion. FH presents with xanthomas and early coronary artery disease, owing to relatively high levels of low-density lipid-cholesterol (LDL-C) compared to hypercholesterolemia without a genetic predisposition. The first clinical manifestation of this condition could be an acute coronary syndrome in undiagnosed and unsuspecting patient. Various clinical criteria are available to make a diagnosis of FH and a clinician should use the one which he is familiar with. Owing to very high LDL-C levels patients often need multiple oral lipid lowering agents to achieve the desired LDL-C goal. There are multiple novel parenteral lipid lowering agents in offing and some are in pipeline with advantage of high potency and weekly or monthly dosing. This case report emphasizes the importance of FH screening and aggressive treatment to decrease morbidity and mortality in the general population.